Eli Lilly and Company
MX ˙ BMV ˙ US5324571083
SecurityMX:LLY / Eli Lilly and Company
InstitutionWebster Bank, N. A.
Latest Disclosed Ownership1,869 shares
Latest Disclosed Value $ 1,719,050
Webster Bank, N. A. reports 5.27% decrease in ownership of LLY / Eli Lilly and Company

On April 17, 2026 - Webster Bank, N. A. filed a 13F-HR form disclosing ownership of 1,869 shares of Eli Lilly and Company (MX:LLY) valued at $1,719,050 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 1,973 shares of Eli Lilly and Company. This represents a change in shares of -5.27% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F ELI LILLY COM 532457108 1,869 -104 -5.27 1,719 -18.92 0.1628
2026-01-23 2025-12-31 13F ELI LILLY COM 532457108 1,973 -16 -0.80 2,120 39.75 0.1989
2025-10-23 2025-09-30 13F ELI LILLY COM 532457108 1,989 -95 -4.56 1,518 -6.59 0.1459
2025-07-08 2025-06-30 13F ELI LILLY COM 532457108 2,084 27 1.31 1,625 -4.36 0.1678
2025-04-04 2025-03-31 13F ELI LILLY COM 532457108 2,057 -40 -1.91 1,699 4.94 0.1867
2025-01-22 2024-12-31 13F Eli Lilly COM 532457108 2,097 142 7.26 1,619 -6.58 0.1739
2024-10-10 2024-09-30 13F Eli Lilly COM 532457108 1,955 60 3.17 1,732 0.99 0.1843
2024-07-12 2024-06-30 13F Eli Lilly COM 532457108 1,895 -87 -4.39 1,716 11.29 0.1881
2024-04-16 2024-03-31 13F Eli Lilly COM 532457108 1,982 56 2.91 1,542 37.34 0.1723
2024-01-23 2023-12-31 13F Eli Lilly COM 532457108 1,926 1,212 169.75 1,123 192.95 0.1375
2023-10-10 2023-09-30 13F Eli Lilly COM 532457108 714 -16 -2.19 384 11.99 0.0519
2023-07-13 2023-06-30 13F Eli Lilly COM 532457108 730 -1,200 -62.18 342 -48.34 0.0442
2023-04-13 2023-03-31 13F Eli Lilly COM 532457108 1,930 0 0.00 663 0.0864
2023-01-18 2022-12-31 13F Eli Lilly COM 532457108 1,930 0 0.00 1 -100.00 0.0954
2022-10-24 2022-09-30 13F Eli Lilly COM 532457108 1,930 0 0.00 624 -0.16 0.0904
2022-07-12 2022-06-30 13F Eli Lilly COM 532457108 1,930 -430 -18.22 625 -7.54 0.0853
2022-04-13 2022-03-31 13F Eli Lilly COM 532457108 2,360 430 22.28 676 26.83 0.0485
2022-01-12 2021-12-31 13F Eli Lilly COM 532457108 1,930 122 6.75 533 27.51 0.0552
2021-10-12 2021-09-30 13F Eli Lilly COM 532457108 1,808 8 0.44 418 1.21 0.0467
2021-07-20 2021-06-30 13F Eli Lilly COM 532457108 1,800 0 0.00 413 22.92 0.0452
2021-05-07 2021-03-31 13F Eli Lilly and COM 532457108 1,800 0 0.00 336 10.53 0.0383
2021-01-07 2020-12-31 13F Eli Lilly and COM 532457108 1,800 0 0.00 304 14.29 0.0357
2020-10-22 2020-09-30 13F Eli Lilly and COM 532457108 1,800 0 0.00 266 -9.83 0.0349
2020-07-09 2020-06-30 13F Eli Lilly and COM 532457108 1,800 -100 -5.26 295 12.17 0.0418
2020-04-21 2020-03-31 13F Eli Lilly COM 532457108 1,900 0 0.00 263 5.20 0.0437
2020-01-14 2019-12-31 13F Eli Lilly COM 532457108 1,900 0 0.00 250 17.37 0.0319
2019-10-01 2019-09-30 13F Eli Lilly COM 532457108 1,900 0 0.00 213 1.43 0.0288
2019-07-11 2019-06-30 13F Eli Lilly COM 532457108 1,900 100 5.56 210 -10.26 0.0289
2019-04-10 2019-03-31 13F Eli Lilly COM 532457108 1,800 0 0.00 234 11.96 0.0335
2019-01-09 2018-12-31 13F Eli Lilly COM 532457108 1,800 0 0.00 209 8.29 0.0337
2018-10-12 2018-09-30 13F Eli Lilly COM 532457108 1,800 0 0.00 193 25.32 0.0269
2018-07-12 2018-06-30 13F Eli Lilly COM 532457108 1,800 0 0.00 154 10.79 0.0222
2018-04-19 2018-03-31 13F Eli Lilly COM 532457108 1,800 0 0.00 139 -8.55 0.0201
2018-01-23 2017-12-31 13F Eli Lilly COM 532457108 1,800 0 0.00 152 -1.30 0.0209
2017-10-12 2017-09-30 13F Eli Lilly COM 532457108 1,800 -203 -10.13 154 -6.10 0.0224
2017-07-12 2017-06-30 13F Eli Lilly COM 532457108 2,003 0 0.00 164 -2.38 0.0243
2017-05-01 2017-03-31 13F Eli Lilly COM 532457108 2,003 -30 -1.48 168 12.75 0.0253
2017-02-15 2016-12-31 13F Eli Lilly COM 532457108 2,033 -1,832 -47.40 149 -34.65 0.0218
2014-04-11 2014-03-31 13F ELI LILLY COMMON STOCK 532457108 3,865 3,865 228 0.0315
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.